Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.
Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.
Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
ZGT has raised $48m from Tsinghua Holdings Capital, CAS Star and others, while University of Cambridge spinout Colorifix has pocketed $22.7m.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
UVC Partners has taken part in the round, which will allow Finn to expand further across the US while bolstering its market position in Europe.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.
Hitachi grows its cell therapy portfolio, SoftBank slims down in India and Foresight Williams backs ID tags for diamonds.
Alternative batteries and green steel get corporate backing, while the dairy industry cleans up its footprint and satellites go hyperspectral.
It is an old joke that nuclear fusion power is 30 years away, and always will be. The joke is now looking outdated as the technology finally reaches a stage where investors feel comfortable writing cheques for hundreds of millions of dollars towards its development.
Global University Venturing is a quarterly magazine and website written for and about universities taking stakes in the spinout companies of staff and students. We help universities to share best practice and to connect with each other, with investors and with other useful parties in the innovation ecosystem. Our aim is to help improve the processes of bringing innovations from academia to the market and facilitate their integration into the business ecosystem.
